JPS5029005B2 - - Google Patents

Info

Publication number
JPS5029005B2
JPS5029005B2 JP47044566A JP4456672A JPS5029005B2 JP S5029005 B2 JPS5029005 B2 JP S5029005B2 JP 47044566 A JP47044566 A JP 47044566A JP 4456672 A JP4456672 A JP 4456672A JP S5029005 B2 JPS5029005 B2 JP S5029005B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP47044566A
Other languages
Japanese (ja)
Other versions
JPS496115A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP47044566A priority Critical patent/JPS5029005B2/ja
Priority to US05/354,883 priority patent/US3940480A/en
Priority to GB2166573A priority patent/GB1395090A/en
Priority to SE7306389A priority patent/SE405446B/xx
Priority to FR7316462A priority patent/FR2183913B1/fr
Priority to DE2323187A priority patent/DE2323187C2/de
Publication of JPS496115A publication Critical patent/JPS496115A/ja
Publication of JPS5029005B2 publication Critical patent/JPS5029005B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2235—Secretins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP47044566A 1972-05-08 1972-05-08 Expired JPS5029005B2 (en:Method)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP47044566A JPS5029005B2 (en:Method) 1972-05-08 1972-05-08
US05/354,883 US3940480A (en) 1972-05-08 1973-04-26 Process for production of stabilized powdery secretin preparation by lyophilization
GB2166573A GB1395090A (en) 1972-05-08 1973-05-07 Stabilized hormone compositions
SE7306389A SE405446B (sv) 1972-05-08 1973-05-07 Sett att framstella ett stabiliserat pulverformigt sekretinpreparat genom frystorkning
FR7316462A FR2183913B1 (en:Method) 1972-05-08 1973-05-08
DE2323187A DE2323187C2 (de) 1972-05-08 1973-05-08 Verfahren zur Herstellung einer stabilisierten, pulverförmigen Secretinzubereitung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47044566A JPS5029005B2 (en:Method) 1972-05-08 1972-05-08

Publications (2)

Publication Number Publication Date
JPS496115A JPS496115A (en:Method) 1974-01-19
JPS5029005B2 true JPS5029005B2 (en:Method) 1975-09-19

Family

ID=12695032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47044566A Expired JPS5029005B2 (en:Method) 1972-05-08 1972-05-08

Country Status (6)

Country Link
US (1) US3940480A (en:Method)
JP (1) JPS5029005B2 (en:Method)
DE (1) DE2323187C2 (en:Method)
FR (1) FR2183913B1 (en:Method)
GB (1) GB1395090A (en:Method)
SE (1) SE405446B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002798A1 (en) * 1978-01-07 1980-12-24 Green Cross Corp Antithrombin preparation and process for obtaining same

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2758578A1 (de) * 1977-12-29 1979-07-05 Hoechst Ag Stabile sekretinzubereitung, verfahren zu ihrer herstellung und ihre verwendung
JPS57169425A (en) * 1981-04-10 1982-10-19 Eisai Co Ltd Composition and method for preventing adsorption of secretin
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法
DE3402466A1 (de) * 1984-01-25 1985-08-01 Hoechst Ag, 6230 Frankfurt Sekretin und dieses enthaltende mittel zur prophylaxe des aspirations-syndroms
SE454514B (sv) * 1985-03-11 1988-05-09 Kabigen Ab Intestinal deggdjurshormonprekursor samt kompositioner innehallande denna
SE454513B (sv) * 1985-03-11 1988-05-09 Kabigen Ab Humant sekretin samt kompositioner innehallande detta
CA1331133C (en) * 1988-03-01 1994-08-02 Michael Jon Pikal Pharmaceutical growth hormone formulations
CA2013474C (en) * 1989-04-20 2000-01-18 Pharmacia Inc. Cyclophosphamide - alanine lyophilizates
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
US5268368A (en) * 1991-05-17 1993-12-07 Erbamont, Inc. Cyclophosphamide--amino acid lyophilizates
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
JP2002501616A (ja) * 1997-05-19 2002-01-15 リプリゲン コーポレーション 自閉的症候群を鑑別診断および治療する際の助けとするための方法
US6197746B1 (en) * 1998-05-19 2001-03-06 Repligen Corporation Method of using secretin for treating autism
ES2679819T3 (es) 2009-11-03 2018-08-31 Grifols Therapeutics Inc. Composición, método y kit para inhibidor de alfa-1 proteinasa
JP6155647B2 (ja) * 2012-01-13 2017-07-05 東洋紡株式会社 フルクトシルバリルヒスチジンオキシダーゼ製剤の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2104344B2 (de) * 1971-01-30 1975-08-21 Hoechst Ag, 6000 Frankfurt Protrahiert wirkendes Sekretin-Präparat

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002798A1 (en) * 1978-01-07 1980-12-24 Green Cross Corp Antithrombin preparation and process for obtaining same

Also Published As

Publication number Publication date
JPS496115A (en:Method) 1974-01-19
DE2323187C2 (de) 1982-10-14
FR2183913A1 (en:Method) 1973-12-21
GB1395090A (en) 1975-05-21
US3940480A (en) 1976-02-24
FR2183913B1 (en:Method) 1977-01-28
SE405446B (sv) 1978-12-11
DE2323187A1 (de) 1973-11-22

Similar Documents

Publication Publication Date Title
JPS5029005B2 (en:Method)
CS154514B1 (en:Method)
CS153677B1 (en:Method)
CS152945B1 (en:Method)
CS152938B1 (en:Method)
CS154522B1 (en:Method)
CH565431A5 (en:Method)
CH578118A5 (en:Method)
CH561843A5 (en:Method)
CH561961A5 (en:Method)
CH562945A5 (en:Method)
CH565093A5 (en:Method)
CH583231A5 (en:Method)
CH569331A5 (en:Method)
CH570331A5 (en:Method)
CH570389A5 (en:Method)
CH570407A5 (en:Method)
CH570503A5 (en:Method)
CH571570A5 (en:Method)
CH572247A5 (en:Method)
CH574326A5 (en:Method)
CH574354A5 (en:Method)
CH575363A5 (en:Method)
CH577786A5 (en:Method)
CH577812A5 (en:Method)